as on February 5, 2026 at 4:02 pm IST
Day's Low
Day's High
5.56%
Downside
14.66%
Upside
52 Week's Low
52 Week's High
5.56%
Downside
252.72%
Upside
as on February 5, 2026 at 4:02 pm IST
Market Cap
₹42.62 Cr
Return on Equity (ROE)
2.78
PE Ratio (TTM)
-7.49
Return on capital employed (ROCE)
7.23
Industry PE ratio
44.27
Beta (LTM)
0.16
P/B Ratio
4.44
Dividend Yield
0PEG Ratio
3.28
Quarterly Earnings Growth YOY
-25.41
EPS (TTM)
2.29
Sector
Diversified
Book Value
13.86
Technical Analysis
Bearish
View Technical Analysis
as on February 5, 2026 at 4:02 pm IST
Indrayani Biotech in the last 5 years
Lowest (-435.71x)
March 30, 2022
Today (-7.49x)
February 4, 2026
Industry (44.27x)
February 4, 2026
Highest (68.45x)
September 21, 2022
Today’s Price to Earnings Ratio: -7.49x
Compare market cap, revenue, PE, and other key metrics of Indrayani Biotech with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 42.62 | 1.82% | 0.82 | 10 | 166 | |
| NA | 45.30 | 15.4% | 0.51 | 4 | 12 | |
| NA | 66.45 | -9.87% | 0.00 | 9 | 257 | |
| NA | 45.59 | 134.72% | 0.53 | 4 | 25 | |
| NA | 12.70 | 68.29% | 0.80 | -1 | 28 |
Get share price movements and forecasts by analysts on Indrayani Biotech.
Source: S&P Global Market Intelligence
Search interest for Indrayani Biotech Ltd Stock has increased by 42% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:42% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Indrayani Biotech.
Indrayani Biotech Ltd’s net profit fell -25.41% since last year same period to ₹0.91Cr in the Q2 2025-2026. On a quarterly growth basis, Indrayani Biotech Ltd has generated 468.75% jump in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 3 quarters, -8.53 Cr → 0.91 Cr (in ₹), with an average increase of 2756.8% per quarter
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 30.16 Cr → 37.75 Cr (in ₹), with an average increase of 20.1% per quarter
Against Peers
![]()
In the last 3 years, Chalet Hotels Ltd has given 140.1% return, outperforming this stock by 226.5%
Against Peers
![]()
In the last 1 year, Chalet Hotels Ltd has given 12.2% return, outperforming this stock by 79.0%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 33.26% of holdings in Dec 2025 quarter
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 63.61% of holdings in Dec 2025 quarter
Price Dip
![]()
In the last 3 months, Indrayani Biotec stock has moved down by -40.2%
| Organisation | Indrayani Biotech Ltd |
| Industry | Diversified |
| CEO | N M Ranganathan |
| E-voting on shares | Click here to vote |
Indrayani Biotech share price today stands at ₹8.46 as on at the close of the market. Indrayani Biotech share today touched a day high of ₹9.7 and a low of ₹7.99.
Indrayani Biotech touched a 52 week high of ₹29.84 and a 52 week low of ₹7.99. Indrayani Biotech share price today i.e. is closed at ₹8.46, which is -71.65% down from its 52 week high and 5.88% up from its 52 week low.
Indrayani Biotech market capitalisation is ₹42.62 Cr as on .
To buy Indrayani Biotech shares, you need to follow these steps:
Indrayani Biotech trading volume is 1.44L as on . This means that 1.44L shares of Indrayani Biotech were bought and sold on the stock market during today's trading session.